Universitätsklinikum Freiburg

Hospital


Location: Freiburg, Germany (DE) DE

ISNI: 0000000094287911

ROR: https://ror.org/03vzbgh69

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Newbornscreening SMA - From Pilot Project to Nationwide Screening in Germany (2023) Müller-Felber W, Blaschek A, Schwartz O, Gläser D, Nennstiel U, Brockow I, Wirth B, et al. Journal article Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry Study (2023) Pechmann A, Behrens M, Dörnbrack K, Tassoni A, Wenzel F, Stein S, Vogt S, et al. Journal article Have attitudes toward epilepsy improved in Germany over the last 50 years? (2023) Thorbecke R, Pfäfflin M, Bien CG, Hamer H, Holtkamp M, Rating D, Schulze-Bonhage A, et al. Journal article Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination (2022) Irrgang P, Gerling J, Kocher K, Lapuente D, Steininger P, Habenicht K, Wytopil M, et al. Journal article Histological evaluation of PAXgene tissue fixation in Barrett's esophagus and esophageal adenocarcinoma diagnostics (2022) Barroux M, Horstmann J, Fricke L, Schoemig L, Werner M, Kraynova E, Kamaradova K, et al. Journal article Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis (2022) Guyon J, Fernandez-Moncada I, Larrieu CM, Bouchez CL, Pagano Zottola AC, Galvis J, Chouleur T, et al. Journal article Case report: Cutaneous pseudolymphoma caused by a Leishmania infantum infection in a patient treated with anti-TNF antibody for plaque psoriasis (2022) Scholl S, Schuster D, Technau-Hafsi K, Stete K, Rieg S, May AM, Bogdan C, Schauer F Journal article 18F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy (2022) Wiltgen T, Fleischmann DF, Kaiser L, Holzgreve A, Corradini S, Landry G, Ingrisch M, et al. Journal article Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial (2022) Zeyen T, Potthoff AL, Nemeth R, Heiland DH, Burger MC, Steinbach JP, Hau P, et al. Journal article T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10 (2022) Ravi VM, Neidert N, Will P, Joseph K, Maier JP, Kückelhaus J, Vollmer L, et al. Journal article